drugset / Trial / NCT00597246

Imaging Brain Tumors With FACBC and Methionine

NCT00597246

NaSingle-groupOpen-labelDiagnostic

Summary

This research protocol makes pictures of brain tumors. The pictures are made with a positron emission tomography (PET) scanner. PET scans use radioactivity to "see" cancer cells. We are using a new kind of PET scan. The new PET scan is called \[18F\]-FACBC PET. We will compare this to the standard PET scan. The standard PET scan is called \[11C\]-methionine PET. We expect these pictures will give us information about your tumor. We also hope to collect information about the amount of radioactivity exposure. We will measure radioactivity exposure to your tumor, brain and other organs. The research study results will be used to support the submission of an investigational new drug (IND) application to the Food and Drug Administration (FDA).

Timeline

Start
2003-05-13
Primary completion
2019-11-27
Completion
2019-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-fluciclovine Diagnostic / imaging agent 370 mbq Intravenous
Subject Methionine Other / unclassified Intravenous

Indications